arrow
W

Wilbur H. Chen

University of Maryland School of Medicine
H指数:33
被引数:4,623

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 2, randomised, placebo-controlled study to evaluate once-daily oral Travelan for the prevention of Travellers’ diarrhoea

一项2期、随机、安慰剂对照研究,评估每日一次口服Travelan预防旅行者腹泻的效果

2026-10-120
OAAI
Persistence of Serum Bactericidal Antibody in the First 2 Years After Immunization With Pentavalent Meningococcal ACWYX Vaccine in Malian Infants and Toddlers

在马拉维婴儿和幼儿中,接种五价脑膜炎球菌ACWYX疫苗后2年内血清杀菌抗体的持久性

2026-07-220
PRE
First-in-Human Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella flexneri 2a Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122

首次人体安全性、遗传稳定性和免疫原性评价:表达产肠毒素大肠杆菌抗原的减毒志贺氏菌2a活载体疫苗株CVD 1208S-122

2026-07-150
PRE
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial

PanChol单剂量口服减毒霍乱疫苗的安全性与免疫原性:一项1a期、双盲、随机、安慰剂对照试验的结果

2026-01-070
OAAI
Evaluating modes of influenza transmission (EMIT-2): Insights from lack of transmission in a controlled transmission trial with naturally infected donors
2026-01-011
PRE
A combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial

一种伤寒与非伤寒沙门氏菌多糖结合疫苗在健康成人中的研究:一项随机、安慰剂对照的1期临床试验

2025-10-080
PRE
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens

抗神经氨酸酶和抗血凝素stalk对不同流感A(H7N9)疫苗方案的反应

VACCINE
IF3.5
2025-02-010
PRE
Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial
2024-09-071
OA
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial

不同启动方案后延迟异源禽流感a (H7N9) 疫苗加强的安全性和免疫原性: 一项随机临床试验

2023-07-193
OA
Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS-CoV-2
2023-03-270
OAAI
The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions

世卫组织非洲和东南亚地区针对流感风险人群的疫苗接种计划的操作可行性

2021-05-042
OAAI